|
Volumn 9, Issue 17, 1999, Pages 2613-2614
|
The design of (-)-(S)-2-nitrooxyethyl 1,4-dihydro-2,6-dimethyl-3-nitro-4-(2-trifluoromethylphenyl)pyridine-5-carboxyla te: A cardioselective positive inotropic derivative of Bay K 8644
a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
1,4 DIHYDRO 2,6 DIMETHYL 5 NITRO 4 [2 (TRIFLUOROMETHYL)PHENYL] 3 PYRIDINECARBOXYLIC ACID METHYL ESTER;
2 NITROOXYETHYL 1,4 DIHYDRO 2,6 DIMETHYL 3 NITRO 4 (2 TRIFLUOROMETHYLPHENYL)PYRIDINE 5 CARBOXYLATE;
CALCIUM CHANNEL;
CALCIUM CHANNEL BLOCKING AGENT;
CALCIUM CHANNEL STIMULATING AGENT;
CARBOXYLIC ACID DERIVATIVE;
LEAD;
NITRIC OXIDE;
UNCLASSIFIED DRUG;
ARTICLE;
CONGESTIVE HEART FAILURE;
DRUG DESIGN;
PARTIAL DRUG SYNTHESIS;
STRUCTURE ACTIVITY RELATION;
STRUCTURE ANALYSIS;
3-PYRIDINECARBOXYLIC ACID, 1,4-DIHYDRO-2,6-DIMETHYL-5-NITRO-4-(2-(TRIFLUOROMETHYL)PHENYL)-, METHYL ESTER;
CALCIUM CHANNEL AGONISTS;
HEART;
MUSCLE, SMOOTH;
MYOCARDIAL CONTRACTION;
NICOTINIC ACIDS;
NITRIC OXIDE;
|
EID: 0033530094
PISSN: 0960894X
EISSN: None
Source Type: Journal
DOI: 10.1016/S0960-894X(99)00445-X Document Type: Article |
Times cited : (9)
|
References (9)
|